Detail Information of Xenobiotics

General Information of Xenobiotics (ID: XEO00693)
Xenobiotics Name	Harmaline
Xenobiotics Type	Pharmaceutical Agent(s)
Classification	Preclinical/Patented Drug
Structure	<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=3564"></iframe>
Structure	3D MOL	2D MOL
PubChem CID	3564
DME(s) Modulated by This Xenobiotics
DME(s) Inhibited by This Xenobiotics
	Cytochrome P450 1A1 (CYP1A1)	DME Info	Homo sapiens	[1]
	Monoamine oxidase type A (MAO-A)	DME Info	Homo sapiens	[2]

References
1	Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms. Food Chem Toxicol. 2012 Feb;50(2):353-62.
2	In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks. Toxicol Lett. 2017 Apr 15;272:84-93.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.